Minneapolis
89°F
eEdition
News & Politics
Sports
Food & Culture
Business
Outdoors
Opinion
Things To Do
Obituaries
More of What Matters to Minnesota
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Minnesota State Top Stocks
Markets
Minnesota Stocks
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Macrogenics
(NQ:
MGNX
)
3.230
-0.030 (-0.92%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Macrogenics
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Why MacroGenics Stock Crushed the Market on Monday
November 14, 2022
Positive momentum continues for the cancer specialist in the wake of its latest earnings report.
Via
The Motley Fool
MacroGenics To Surge 138%? Plus This Analyst Sees $50 For Exact Sciences
November 14, 2022
BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares...
Via
Benzinga
360 DigiTech, HUTCHMED And Some Other Big Stocks Moving Higher In Today's Pre-Market Session
November 14, 2022
U.S. stock futures traded lower this morning. Here are some big stocks recording gains in today’s pre-market trading session.
Via
Benzinga
Blue Star (NASDAQ: BSFC) Insiders Are Buying Stock
November 11, 2022
One indicator of where a company’s stock might be going in the future can be understood by what insiders may be thinking of the Company’s current stock price and near-term future outlook. Insiders are...
Via
Benzinga
MacroGenics (MGNX) Q3 2022 Earnings Call Transcript
November 03, 2022
MGNX earnings call for the period ending September 30, 2022.
Via
The Motley Fool
What 5 Analyst Ratings Have To Say About Macrogenics
August 09, 2022
Macrogenics (NASDAQ:MGNX) has observed the following analyst ratings within the last quarter:
Via
Benzinga
MacroGenics Jumps Biotech Layoff Bandwagon, Cuts 15% Of Workforce
August 09, 2022
Via
Benzinga
Macrogenics: Q2 Earnings Insights
August 08, 2022
Macrogenics (NASDAQ:MGNX) reported its Q2 earnings results on Monday, August 8, 2022 at 04:00 PM. Here's what investors need to know about the announcement.
Via
Benzinga
Why MacroGenics Stock Popped Again Today
November 07, 2022
Investors and analysts alike are getting more bullish on the company in the wake of its third-quarter results.
Via
The Motley Fool
Why MacroGenics Stock Blasted Higher Today
November 04, 2022
A quarter that was far better than expected gets investors excited about the biotech at the end of the week.
Via
The Motley Fool
12 Health Care Stocks Moving In Friday's Intraday Session
November 04, 2022
Gainers
Via
Benzinga
MacroGenics to Participate in Upcoming Investor Conferences
November 02, 2022
From
MacroGenics, Inc.
Via
GlobeNewswire
Provention Bio's Second Try, Apellis's Eye Disorder Drug Review, 3 Adcom Verdicts And More: November's Key PDUFA Catalysts Biotech Investors Must Know
November 01, 2022
October proved to be a mixed month for the Food and Drug Administration’s regulatory decisions. Two new molecular entities, or NMEs, were approved during the month, bringing the tally for the...
Via
Benzinga
Why MediaAlpha Shares Jumped Around 30%; Here Are 112 Biggest Movers From Friday
November 07, 2022
Gainers
Via
Benzinga
Why Yelp Shares Are Trading Lower By 15%? Here Are 86 Stocks Moving In Friday's Mid-Day Session
November 04, 2022
Gainers
Via
Benzinga
MacroGenics Announces Date of Third Quarter 2022 Financial Results Conference Call
October 26, 2022
From
MacroGenics, Inc.
Via
GlobeNewswire
$7.5 Million Bet On Local Bounti? Check Out These 3 Penny Stocks Insiders Are Buying
October 26, 2022
US crude oil futures traded higher this morning on Wednesday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or...
Via
Benzinga
$1.8 Million Bet On MacroGenics? Check Out These 3 Penny Stocks Insiders Are Buying
October 24, 2022
The Dow Jones traded higher by over 400 points on Monday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or concern...
Via
Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
October 21, 2022
Gainers
Via
Benzinga
Why Huntington Bancshares Shares Surged Around 10%; Here Are 72 Biggest Movers From Friday
October 24, 2022
Gainers Huadi International Group Co., Ltd. (NASDAQ: HUDI) jumped 89.3% to close at $58.92 on Friday.
Via
Benzinga
Analyst Ratings for Macrogenics
October 18, 2022
Over the past 3 months, 5 analysts have published their opinion on Macrogenics (NASDAQ:MGNX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
MacroGenics Shares Jump On Gilead Licensing Pact For Blood Cancer Candidates
October 17, 2022
Via
Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
October 17, 2022
Gainers Acorda Therapeutics (NASDAQ:ACOR) shares increased by 46.1% to $0.49 during Monday's pre-market session. The company's market cap stands at $11.9 million.
Via
Benzinga
Gilead and MacroGenics Announce Oncology Collaboration to Develop Bispecific Antibodies
October 17, 2022
From
Gilead Sciences, Inc.
Via
Business Wire
This Analyst Slashes PT On Meta Platforms, Plus Mizuho Predicts $440 For Adobe
September 12, 2022
Mizuho cut the price target for Adobe Inc (NASDAQ: ADBE) from $480 to $440. Adobe shares fell 1.3% to $389.82 in pre-market trading.
Via
Benzinga
Where Macrogenics Stands With Analysts
August 29, 2022
Over the past 3 months, 6 analysts have published their opinion on Macrogenics (NASDAQ:MGNX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a...
Via
Benzinga
SVB Leerink Slashes Price Target On This Stock By Over 73%, Plus This Analyst Predicts $56 For Toll Brothers
August 29, 2022
Citigroup raised the price target for MacroGenics, Inc. (NASDAQ: MGNX) from $13 to $16. MacroGenics shares rose 4.8% to $3.90 in pre-market trading.
Via
Benzinga
Earnings Preview: Macrogenics
August 05, 2022
Macrogenics (NASDAQ:MGNX) is set to give its latest quarterly earnings report on Monday, 2022-08-08. Here's what investors need to know before the announcement. Analysts estimate that Macrogenics will...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
August 01, 2022
Gainers Conformis (NASDAQ:CFMS) shares moved upwards by 13.2% to $0.29 during Monday's after-market session. The company's market cap stands at $53.5 million.
Via
Benzinga
This Healthcare Stock Tumbled 43%; Here Are 88 Biggest Movers From Yesterday
July 29, 2022
Gainers Athersys, Inc. (NASDAQ: ATHX) climbed 71.1% to close at $0.3250 on Thursday after gaining 10% on Wednesday. Athersys is expected to release its Q2 financial results on Thursday, August 11,...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.